Latest Posts


Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More


Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Innoplexus @ Machine Intelligence Summit, Berlin 2017

Innoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine Intelligence Summit to be held on 14th July 2017, in Berlin, Germany.

The panel discussion is around “From Past Learning to Predictive Future” at 13:45 CET on Friday at Deutsche Telekom Hauptstadtrepräsentanz Französische Straße 33a-c, 10117 Berlin. The other participants on the panel are Prof. Christoph von der Malsburg, Barbara Pogorzelska, Josh Chen.

The discussion is on how machine intelligence is used to accomplish the tasks on reducing efforts and complexity in understanding the data sets to recognise the patterns and to predict future behaviours. The panel of cross industry experts shall discuss use cases where machine intelligence predictions have real impact.

Other team members from Innoplexus who are going to be present at the event are:

  • Mr. Gaurav Tripathi, Co-founder and CTO
  • Ms Varsha Rohani, Senior Manager, Corporate Development
  • Mr Yannik Schelske, Data Scientist
  • Mr. Tanay Gahlot, Software Engineer working in our Deep Learning team

If you are in Berlin on 14th July, please do drop by to listen to our views on AI, Deep Learning and Machine Learning, and to meet our amazing team members.

About the Event

Machine Intelligence Summit, organised by SearchInk, gathers some of the most brilliant minds in the field of Artificial Intelligence to discuss the stakes of Deep Learning and Machine Intelligence.

About Innoplexus

Innoplexus caters to Life sciences industry offering Data as a Service (DaaS) and Continuous Analytics as a Service (CAaaS) products. We leverage Artificial Intelligence and advanced analytics to help reduce the drug development time from synthesis to approval, significantly.

We use proprietary algorithms and technologies to help global Life Sciences and Pharmaceutical organisations across all stages (Pre-clinical, clinical, regulatory and commercial) of drug development.

We automate the collection, curation, aggregation and analysis, of billions of data points from thousands of data sources, using machine learning, network analysis, ontologies, computer vision and entity normalisation.

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…